Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Barrett

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Antiviral Research|May 24, 2014
Solid phase assay for comparing reactivation rates of neuraminidases of influenza wild type and resistant mutants after inhibitor removalSusan Barrett, Jennifer L McKimm-Breschkin
Antiviral Research|December 16, 2014
Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociationJennifer L McKimm-Breschkin, Susan Barrett
Journal of Veterinary Emergency and Critical Care (San Antonio, Tex. : 2001)|August 20, 2016
Retrospective evaluation of the use of glucagon infusion as adjunctive therapy for hypoglycemia in dogs: 9 cases (2005-2014)Kristen Datte, Julien Guillaumin, Susan Barrett, et al.
Antiviral Research|September 15, 2015
Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN)Victor A Streltsov, Pat Pilling, Susan Barrett, et al.
Journal of the American Veterinary Medical Association|August 2, 2017
What Is Your Diagnosis? Tooth root abscessMaria C Jugan, Kristin E Holland, Susan Barrett, et al.
Plos One|August 23, 2011
Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza virusesSusan Barrett, Peter G Mohr, Peter M Schmidt, et al.
Maturitas|March 8, 2014
Feeling that life is not worth living (death thoughts) among middle-aged, Australian women providing unpaid careSiobhan T O'Dwyer, Wendy Moyle, Nancy A Pachana, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2012
In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivirJennifer L McKimm-Breschkin, Christina Rootes, Peter G Mohr, et al.
The Journal of Arthroplasty|October 10, 2006
Steady-state penetration rates of electron beam-irradiated, highly cross-linked polyethylene at an average 45-month follow-upCharles R Bragdon, Susan Barrett, John M Martell, et al.
Antiviral Research|June 25, 2019
Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutantJennifer L McKimm-Breschkin, Susan Barrett, Charley McKenzie-Kludas, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Antiviral Research|May 24, 2014
Solid phase assay for comparing reactivation rates of neuraminidases of influenza wild type and resistant mutants after inhibitor removalSusan Barrett, Jennifer L McKimm-Breschkin
Antiviral Research|December 16, 2014
Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociationJennifer L McKimm-Breschkin, Susan Barrett
Journal of Veterinary Emergency and Critical Care (San Antonio, Tex. : 2001)|August 20, 2016
Retrospective evaluation of the use of glucagon infusion as adjunctive therapy for hypoglycemia in dogs: 9 cases (2005-2014)Kristen Datte, Julien Guillaumin, Susan Barrett, et al.
Antiviral Research|September 15, 2015
Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN)Victor A Streltsov, Pat Pilling, Susan Barrett, et al.
Journal of the American Veterinary Medical Association|August 2, 2017
What Is Your Diagnosis? Tooth root abscessMaria C Jugan, Kristin E Holland, Susan Barrett, et al.
Plos One|August 23, 2011
Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza virusesSusan Barrett, Peter G Mohr, Peter M Schmidt, et al.
Maturitas|March 8, 2014
Feeling that life is not worth living (death thoughts) among middle-aged, Australian women providing unpaid careSiobhan T O'Dwyer, Wendy Moyle, Nancy A Pachana, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2012
In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivirJennifer L McKimm-Breschkin, Christina Rootes, Peter G Mohr, et al.
The Journal of Arthroplasty|October 10, 2006
Steady-state penetration rates of electron beam-irradiated, highly cross-linked polyethylene at an average 45-month follow-upCharles R Bragdon, Susan Barrett, John M Martell, et al.
Antiviral Research|June 25, 2019
Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutantJennifer L McKimm-Breschkin, Susan Barrett, Charley McKenzie-Kludas, et al.
Pageof 2